Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 1/20 | 0.44 |
| ▸ | GSTA1 | P08263 | 6/20 | 0.42 |
| ▸ | GSTP1 | P09211 | 6/20 | 0.42 |
| ▸ | PTPRC | P08575 | 4/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.42 |
| ▸ | PTPRB | P23467 | 4/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15541243 | 0.82 | KDM4E (0.43) | CD69SMN1; SMN2MAPK1ALDH1A1LGALS1 | |
| SCHEMBL31326111 | 0.76 | GSTA1 (0.56) | CD69GSTA1GSTP1PTPRCPTPN2 | |
| SCHEMBL12856857 | 0.76 | GSTA1 (0.56) | CD69GSTA1GSTP1PTPRCPTPN2 | |
| Hydroxyamine SCHEMBL11037119 | 0.76 | CD69 (0.44) | CD69SMN1; SMN2MAPK1MEN1ALDH1A1 | |
| SCHEMBL13686090 | 0.75 | TLR4 (0.38) | GSTA1GSTP1PTPRCPTPN2PTPN1 | |
| SCHEMBL6067606 | 0.75 | GSTA1 (0.57) | CD69GSTA1GSTP1PTPRCPTPN2 | |
| SCHEMBL30702676 | 0.75 | GSTA1 (0.57) | CD69GSTA1GSTP1PTPRCPTPN2 | |
| SCHEMBL1144971 | 0.72 | GSTA1 (0.41) | CD69GSTA1GSTP1PTPRCPTPN2 | |
| SCHEMBL759347 | 0.72 | GSTA1 (0.41) | CD69GSTA1GSTP1PTPRCPTPN2 | |
| SCHEMBL8556505 | 0.69 | GSTA1 (0.41) | CD69GSTA1GSTP1PTPRCPTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070027278-A1 | Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom | DOW GLOBAL TECHNOLOGIES LLC | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027278-A1 | Multifunctional monomers containing bound mesogenic poragen forming moieties and polyarylene compositions therefrom | LRBA, CD74, BMP2 | CD69 1531/4885GSTA1 646/4885GSTP1 1219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.